07:32 AM EDT, 08/08/2024 (MT Newswires) -- Insmed ( INSM ) reported a Q2 net loss Thursday of $1.94 per diluted share, widening from $1.78 a year earlier.

Analysts polled by Capital IQ expected a loss of $1.19.

Net product revenue for the quarter ended June 30 was $90.3 million, up from $77.2 million a year earlier.

Analysts surveyed by Capital IQ expected $87.8 million.

The company said it had almost $1.25 billion in cash and cash equivalents as of June 30.

The stock was down 3.5% in recent premarket activity.

Price: 68.50, Change: -2.49, Percent Change: -3.51